Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88

Bioorg Med Chem. 2008 Jan 15;16(2):699-709. doi: 10.1016/j.bmc.2007.10.044. Epub 2007 Oct 18.

Abstract

A stepwise synthetic route to the mannooligosaccharides from the neutral fraction of Pichia holstii phosphomannan hydrolysate, including a tetrasaccharylamine component, was developed using only two or three readily available d-mannose building blocks. These compounds were sulfonated to give the corresponding sulfated oligosaccharides which are closely related to the constituents of the anticancer agent PI-88. The synthetic approach is well suited to the preparation of analogues as demonstrated by the synthesis of a series of (1-->3)-linked mannooligosaccharides. The inhibitory activity of the sulfated oligosaccharides against heparanase was determined using a Microcon ultrafiltration assay. The tetra- and pentasaccharides were potent competitive inhibitors of heparanase (K(i)=200-280nM) whilst the shorter di- and trisaccharides were partial competitive inhibitors and did not completely inhibit the enzyme even at very high concentrations.

MeSH terms

  • Angiogenesis Inhibitors / chemical synthesis*
  • Angiogenesis Inhibitors / chemistry
  • Angiogenesis Inhibitors / pharmacology*
  • Combinatorial Chemistry Techniques
  • Dose-Response Relationship, Drug
  • Glucuronidase / antagonists & inhibitors*
  • Glucuronidase / blood
  • Humans
  • Molecular Structure
  • Oligosaccharides / chemical synthesis*
  • Oligosaccharides / chemistry
  • Oligosaccharides / pharmacology*
  • Pichia / chemistry*
  • Sulfuric Acid Esters / chemical synthesis*
  • Sulfuric Acid Esters / chemistry
  • Sulfuric Acid Esters / pharmacology*

Substances

  • Angiogenesis Inhibitors
  • Oligosaccharides
  • Sulfuric Acid Esters
  • phosphomannopentaose sulfate
  • heparanase
  • Glucuronidase